ATS GUIDELINES Bundle

Nontuberculous Myobacterial Pulmonary Disease

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1279658

Contents of this Issue

Navigation

Page 7 of 13

8 Treatment Table 3. Dosing Guidelines for Drugs Used in the Management of NTM Pulmonary Disease Drug Daily Dosing Thrice Weekly Dosing Hepatic Impairment Renal Impairment Oral Azithromycin 250–500 mg per day 500 mg per day N/A N/A Ciprofloxacin 500–750 mg twice per day N/A N/A 250–500 mg dosed at intervals according to CrCl Clarithromycin 500 mg twice per day 500 mg twice per day N/A Reduce dose by 50% if CrCl <30 mL/min Clofazimine a 100–200 mg per day N/A Caution in severe hepatic impairment N/A Doxycycline 100 mg once to twice a day N/A N/A N/A Ethambutol 15 mg/kg per day 25 mg/kg per day N/A Increase dosing interval (eg, 15–25 mg/kg, 3 times per week) Isoniazid 5 mg/kg up to 300 mg per day N/A Caution N/A Linezolid 600 mg once or twice per day b N/A N/A N/A Moxifloxacin 400 mg per day N/A N/A N/A Rifabutin 150–300 mg per day (150 mg per day with clarithromycin) 300 mg per day Caution Reduce dose by 50% if CrCl <30 mL/min Rifampicin (rifampin) 10 mg/kg (450 mg or 600 mg ) per day 600 mg per day Caution N/A Trimethoprim/ sulfamethoxazole 800 mg/160 mg tab twice daily N/A Caution Reduce dose by 50% if CrCl 5–30 mL/min

Articles in this issue

view archives of ATS GUIDELINES Bundle - Nontuberculous Myobacterial Pulmonary Disease